Etiology of ovarian cancer: A proposed mechanism

Medical Hypotheses

Volumn 52, Issue 1, 1999, Pages 23-26

  Ghahremani, M ^a   Foghi, A ^a   Dorrington, J H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

APOPTOSIS; CARCINOGENESIS; EPITHELIUM CELL; FEMALE; HUMAN; OVARY CANCER; OVARY CYST; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; STROMA;

EID: 0033047923     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1997.0620     Document Type: Article

References (18)

1. Green M., Clark J., Blayroy D. The epidemiology of ovarian cancer. Semin Oncol 1984; 11: 209-226.
2. Balasch J., Barri P. Follicular stimulation and ovarian cancer. Hum Reprod 1993; 8: 990-996.
3. Perez R. P., Godwin A. K., Hamilton T. C. Ovarian cancer biology. Semin Oncol 1991; 18: 186-204.
4. Piver M. S., Baker T. R., Piedmonte M., Sandecki A. M. Epidemiology and etiology of ovarian cancer. Semin Oncol 1991; 18: 177-185.
5. Whittemore A. S., Harris R., Itnyre J. And the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of twelve US case control studies. II. Invasive epithelial cancers in white women. Am J Epidemiol 1992; 136: 1184-1203.
6. Rossing M. A., Daling J. R., Weiss N. S., Moore D. E., Self S. G. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331: 771-776.
7. Fathalla M. F. Incessant ovulation - A factor in ovarian neoplasm? Lancet 1971; 2: 163.
8. Cramer D. W., Welch W. R. Determinants of ovarian cancer risk. J Natl Cancer Inst 1983; 71: 717-721.
9. Bell D. A., Scully R. E. Early de novo ovarian carcinoma. Cancer 1994; 73: 1859-1864.
10. Nagata S., Golstein P. The Fas death factor. Science 1994; 267: 1449-1456.
11. Suda T., Takahashi T., Golstein P., Negata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis family. Cell 1993; 75: 1169-1178.
12. Itoh N., Yonehara S., Ishii A. et al. The polypeptide encoded by the cDna for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-243.
13. Watanabe-Fukunaga R., Brannan C. I., Itoh N. et al. The cDna structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148: 1274-1280.
14. Guo M. W., Mori E., Xu J. P., Mori T. Identification of Fas antigen associated with apoptotic cell death in murine ovary. Biochem Biophys Res Commun 1994; 203: 1438-1446.
15. Hakuno N., Koji T., Yano T. et al. Fas/Apo-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicular atresia. Endocrinology 1996; 137: 1938-1948.
16. Quirk S. M., Cowan R. G., Joshi S. G., Henrikson K. P. Fas antigen mediated apoptosis in human granulosa/luteal cells. Biol Reprod 1995; 52: 279-287.
17. Foghi A., Teerds K. J., van der Donk H., Dorrington J. Fas Induced Apoptosis in Rat Thecal/Interstitial Cells Signals Through Sphingomyelin-Ceramide Pathway. Submitted for publication.
18. Ghahremani M., Foghi A., Dorrington J. Activation of Fas Ligand/Receptor System Kills Ovarian Cancer Cells by an Apoptotic Mechanism. Submitted for publication.